CTSO: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net loss	-2,701	469
Amortization of debt discount	571	381
Depreciation and amortization	1,137	773
Amortization of right-of-use asset	109	72
Write-off of patent cost	176	-
Write-off of inventory	253	253
Bad debt expense	17	9
Stock-based compensation	1,879	1,391
Foreign currency transaction gains	9,128	9,192
Accounts receivable	-560	-257
Inventories	1,247	925
Prepaid expenses and other current assets	-989	-1,897
Accounts payable and accrued expenses	-167	-360
Net cash used in operating activities	-7,552	-4,975
Purchases of property and equipment	56	39
Payments for patent costs	68	140
Net cash used in investing activities	-124	-179
Proceeds from exercise of common stock warrants	1,439	1,439
Proceeds from rights offering, net of fees incurred	5,392	5,392
Net cash provided by financing activities	6,831	6,831
Effect of exchange rates on cash	139	285
Net change in cash, cash equivalents, and restricted cash	-706	1,962
Cash and cash equivalents at beginning of period	9,764	-
Cash and cash equivalents at end of period	9,058	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

CTSO: the cashflow